290 related articles for article (PubMed ID: 29751764)
1. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
Yuba TY; Novaes HMD; de Soárez PC
Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
[TBL] [Abstract][Full Text] [Related]
2. Health technology assessment in Australia: a role for clinical registries?
Scott AM
Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
[TBL] [Abstract][Full Text] [Related]
3. Health technology assessment in Brazil - an international perspective.
Lima SGG; Brito C; Andrade CJC
Cien Saude Colet; 2019 May; 24(5):1709-1722. PubMed ID: 31166506
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.
Caetano R; Silva RMD; Pedro ÉM; Oliveira IAG; Biz AN; Santana P
Cien Saude Colet; 2017 Aug; 22(8):2513-2525. PubMed ID: 28793068
[TBL] [Abstract][Full Text] [Related]
5. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
6. Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions.
Wong CKH; Wu O; Cheung BMY
Appl Health Econ Health Policy; 2018 Feb; 16(1):5-14. PubMed ID: 28702874
[TBL] [Abstract][Full Text] [Related]
7. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
Pereira VC; Barreto JOM; Neves FADR
PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
[TBL] [Abstract][Full Text] [Related]
8. Decision criteria for resource allocation: an analysis of CONITEC oncology reports.
Campolina AG; Yuba TY; Soárez PC
Cien Saude Colet; 2022 Jul; 27(7):2563-2572. PubMed ID: 35730828
[TBL] [Abstract][Full Text] [Related]
9. Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System.
Cardoso MMA; Thabane L; Andrade LGM; Curado DDSP; Komoda DS; Machado-Rugolo J; Lima SAM; Weber SAT
Value Health Reg Issues; 2023 Sep; 37():18-22. PubMed ID: 37196546
[TBL] [Abstract][Full Text] [Related]
10. IMPACT OF HEALTH TECHNOLOGY ASSESSMENT REPORTS ON HOSPITAL DECISION MAKERS - 10-YEAR INSIGHT FROM A HOSPITAL UNIT IN SHERBROOKE, CANADA: IMPACT OF HEALTH TECHNOLOGY ASSESSMENT ON HOSPITAL DECISIONS.
Poder TG; Bellemare CA; Bédard SK; Fisette JF; Dagenais P
Int J Technol Assess Health Care; 2018 Jan; 34(4):393-399. PubMed ID: 30021663
[TBL] [Abstract][Full Text] [Related]
11. Patient and public involvement in health technology decision-making processes in Brazil.
Lopes ACF; Novaes HMD; Soárez PC
Rev Saude Publica; 2020; 54():136. PubMed ID: 33331420
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of drugs for rare diseases in Brazil: is it possible to have full access to these patients?
Biglia LV; Mendes SJ; Lima TM; Aguiar PM
Cien Saude Colet; 2021 Nov; 26(11):5547-5560. PubMed ID: 34852089
[TBL] [Abstract][Full Text] [Related]
13. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
Allen N; Walker SR; Liberti L; Salek S
Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
[TBL] [Abstract][Full Text] [Related]
14. Defining the scope of health technology assessment and types of health economic evaluation.
Tanvejsilp P; Ngorsuraches S
J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
[TBL] [Abstract][Full Text] [Related]
15. [Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].
Novaes HM; Elias FT
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S7-16. PubMed ID: 25402252
[TBL] [Abstract][Full Text] [Related]
16. QUALITY OF HEALTH TECHNOLOGY ASSESSMENT REPORTS PREPARED FOR THE MEDICAL SERVICES ADVISORY COMMITTEE.
Hua M; Boonstra T; Kelly PJ; Wilson A; Craig JC; Webster AC
Int J Technol Assess Health Care; 2016 Jan; 32(4):315-323. PubMed ID: 27691988
[TBL] [Abstract][Full Text] [Related]
17. [The incorporation of nusinersen by the Brazilian Unified National Health System: critical thoughts on the institutionalization of health technology assessment in Brazil].
Caetano R; Hauegen RC; Osorio-de-Castro CGS
Cad Saude Publica; 2019 Aug; 35(8):e00099619. PubMed ID: 31483045
[TBL] [Abstract][Full Text] [Related]
18. Opportunities to improve reporting of rapid response in health technology assessment.
de Almeida MO; Montezuma T; de Oliveira Júnior HA; Ferri CP
Int J Technol Assess Health Care; 2021 Dec; 38(1):e4. PubMed ID: 36317686
[TBL] [Abstract][Full Text] [Related]
19. Development of health technology assessment in China: New challenges.
Chen Y; He Y; Chi X; Wei Y; Shi L
Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354
[TBL] [Abstract][Full Text] [Related]
20. Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.
Schmitz S; McCullagh L; Adams R; Barry M; Walsh C
Pharmacoeconomics; 2016 Sep; 34(9):925-37. PubMed ID: 27034245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
